Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021; https://doi.org/10.3322/caac.21660 .

Afonso J, Freitas R, Lobo F, Morais A, Oliveira J, Amaro T, et al. Urothelial bladder cancer progression: lessons learned from the bench. J Cancer Metastasis Treat. 2015. https://doi.org/10.4103/2394-4722.157377.

Article  Google Scholar 

Narayanan S, Srinivas S. Incorporating VEGF-targeted therapy in advanced urothelial cancer. Ther Adv Med Oncol. 2017. https://doi.org/10.1177/1758834016667179.

Article  PubMed  Google Scholar 

Fus ŁP, Górnicka B. Role of angiogenesis in urothelial bladder carcinoma. Cent European J Urol. 2016. https://doi.org/10.5173/ceju.2016.830.

Article  PubMed  PubMed Central  Google Scholar 

Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis–correlation in invasive breast carcinoma. N Engl J Med. 1991. https://doi.org/10.1056/NEJM199101033240101.

Article  PubMed  Google Scholar 

Bochner BH, Cote RJ, Weidner N, Groshen S, Chen S, Skinner DG, et al. Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. JNCI: Journal of the National Cancer Institute. 1995; https://doi.org/10.1093/jnci/87.21.1603 .

El Gehani K, Al-Kikhia L, Mansuri N, Syrjänen K, Al-Fituri O, Adam E. Angiogenesis in urinary bladder carcinoma as defined by microvessel density (MVD) after immunohistochemical staining for Factor VIII and CD31. Libyan J Med. 2011. https://doi.org/10.3402/ljm.v6i0.6016.

Article  PubMed  PubMed Central  Google Scholar 

Huang J, Ma X, Chen X, Liu X, Zhang B, Minmin L, et al. Microvessel density as a prognostic factor in bladder cancer: a systematic review of literature and meta-analysis. Cancer Biomark. 2014. https://doi.org/10.3233/CBM-140417.

Article  PubMed  Google Scholar 

Friedrich MG, Toma MI, Petri S, Cheng JC, Hammerer P, Erbersdobler A, et al. Expression of Maspin in non-muscle invasive bladder carcinoma: correlation with tumor angiogenesis and prognosis. Eur Urol. 2004. https://doi.org/10.1016/j.eururo.2003.12.005.

Article  PubMed  Google Scholar 

Lin Z, Chen S, Ye C, Zhu S. Nitric oxide synthase expression in human bladder cancer and its relation to angiogenesis. Urol Res. 2003. https://doi.org/10.1007/s00240-003-0302-9.

Article  PubMed  Google Scholar 

Teodoro JG, Evans SK, Green MR. Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome. J Mol Med. 2007. https://doi.org/10.1007/s00109-007-0221-2.

Article  PubMed  Google Scholar 

•• Nowak-Sliwinska P, Alitalo K, Allen E, Anisimov A, Aplin AC, Auerbach R, et al. Consensus guidelines for the use and interpretation of angiogenesis assays. Angiogenesis. 2018; https://doi.org/10.1007/s10456-018-9613-x. A comprehensive guideline providing a global review of in vivo, ex vivo, and in vitro angiogenic assays that are available for the evaluation of angiogenesis and highlights critical aspects that are relevant for their execution and proper interpretation.

Sardari Nia P, Colpaert C, Vermeulen P, Weyler J, Pezzella F, Van Schil P, et al. Different growth patterns of non-small cell lung cancer represent distinct biologic subtypes. Ann Thorac Surg. 2008. https://doi.org/10.1016/j.athoracsur.2007.08.054.

Article  PubMed  Google Scholar 

Fonsatti E, Nicolay HJM, Altomonte M, Covre A, Maio M. Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours. Cardiovasc Res. 2010. https://doi.org/10.1093/cvr/cvp332.

Article  PubMed  Google Scholar 

Burrows FJ, Derbyshire EJ, Tazzari PL, Amlot P, Gazdar AF, King SW, et al. Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy. Clin Cancer Res. 1995;1(12):1623–34.

CAS  PubMed  Google Scholar 

Fonsatti E, Jekunen AP, Kairemo KJ, Coral S, Snellman M, Nicotra MR, et al. Endoglin is a suitable target for efficient imaging of solid tumors: in vivo evidence in a canine mammary carcinoma model. Clin Cancer Res. 2000;6(5):2037–43.

CAS  PubMed  Google Scholar 

Miller DW, Graulich W, Karges B, Stahl S, Ernst M, Ramaswamy A, et al. Elevated expression of endoglin, a component of the TGF-β-receptor complex, correlates with proliferation of tumor endothelial cells. Int J Cancer. 1999. https://doi.org/10.1002/(sici)1097-0215(19990517)81:4%3C568::aid-ijc11%3E3.0.co;2-x.

Article  PubMed  Google Scholar 

Fonsatti E, Vecchio LD, Altomonte M, Sigalotti L, Nicotra MR, Coral S, et al. Endoglin: an accessory component of the TGF-β-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies. J Cell Physiol. 2001. https://doi.org/10.1002/jcp.1095.

Article  PubMed  Google Scholar 

Wikström P, Lissbrant IF, Stattin P, Egevad L, Bergh A. Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer. Prostate. 2002. https://doi.org/10.1002/pros.10083.

Article  PubMed  Google Scholar 

Miyata Y, Sagara Y, Watanabe S, Asai A, Matsuo T, Ohba K, et al. CD105 is a more appropriate marker for evaluating angiogenesis in urothelial cancer of the upper urinary tract than CD31 or CD34. Virchows Arch. 2013. https://doi.org/10.1007/s00428-013-1463-8.

Article  PubMed  PubMed Central  Google Scholar 

Agrawal U, Mishra AK, Salgia P, Verma S, Mohanty NK, Saxena S. Role of tumor suppressor and angiogenesis markers in prediction of recurrence of non muscle invasive bladder cancer. Pathol Oncol Res. 2011. https://doi.org/10.1007/s12253-010-9287-1.

Article  PubMed  Google Scholar 

Mousa HM, Jassem AN and Hussain MJ. The Endoglin (CD105) Expression as a marker of tumour vasculature in urinary bladder tumours of Iraqi patients. Mesopotamia Environ J. 2017;SIC:93–8.

• Ollauri-Ibáñez C, Ayuso-Íñigo B and Pericacho M. Hot and cold tumors: is endoglin (CD105) a potential target for vessel normalization?. Cancers. 2021; https://doi.org/10.3390/cancers13071552 . This article highlights the role of endoglin as a predictor of immunosuppressive microenvironment and its potential usefulness in predicting patient response to immunotherapy.

•• Adamo A, Bruno A, Menallo G, Francipane MG, Fazzari M, Pirrone R, et al. Blood vessel detection algorithm for tissue engineering and quantitative histology. Ann Biomed Eng. 2022; https://doi.org/10.1007/s10439-022-02923-2. A blood vessel detection algorithm is provided as an open-source application working on different operating systems. This application facilitates histopathological quantification of blood vessels in immunohistochemistry sections.

Zee Y, O’Connor JPB, Parker GJM, Jackson A, Clamp AR, Taylor MB, et al. Imaging angiogenesis of genitourinary tumors. Nat Rev Urol. 2010. https://doi.org/10.1038/nrurol.2009.262.

Article  PubMed  Google Scholar 

Agrawal S. The basic molecular biology of angiogenesis and its implication in anticancer therapeutics. Arch Int Surg. 2015. https://doi.org/10.4103/2278-9596.167472.

Article  Google Scholar 

Bernardini S, Fauconnet S, Chabannes E, Henry PC, Adessi G, Bittard H. Serum levels of vascular endothelial growth factor as a prognostic factor in bladder cancer. J Urol. 2001. https://doi.org/10.1016/S0022-5347(05)65752-7.

Article  PubMed  Google Scholar 

Pignot G, Bieche I, Vacher S, Güet C, Vieillefond A, Debré B, et al. Large-scale Real-time reverse transcription-PCR approach of angiogenic pathways in human transitional cell carcinoma of the bladder: identification of VEGFA as a major independent prognostic marker. Eur Urol. 2009. https://doi.org/10.1016/j.eururo.2008.05.027.

Article  PubMed  Google Scholar 

Huang Z, Zhang M, Chen G, Wang W, Zhang P, Yue Y, et al. Bladder cancer cells interact with vascular endothelial cells triggering EGFR signals to promote tumor progression. Int J Oncol. 2019. https://doi.org/10.3892/ijo.2019.4729.

Article  PubMed  PubMed Central  Google Scholar 

Sankhwar M, Sankhwar SN, Abhishek A, Rajender S. Clinical significance of the VEGF level in urinary bladder carcinoma. Cancer biomark. 2015. https://doi.org/10.3233/CBM-150478.

Article  PubMed  Google Scholar 

Mori K, Schuettfort VM, Katayama S, Laukhtina E, Pradere B, Quhal F, et al. The value of preoperative plasma VEGF levels in urothelial carcinoma of the bladder treated with radical cystectomy. Eur Urol focus. 2022. https://doi.org/10.1016/j.euf.2021.08.006.

Article  PubMed  Google Scholar 

• Ghafouri S, Burkenroad A, Pantuck M, Almomani B, Stefanoudakis D, Shen J, et al. VEGF inhibition in urothelial cancer: the past, present and future. World J Urol. 2021; https://doi.org/10.1007/s00345-020-03213-z. A review article summarising the current therapeutic challenges associated with anti-angiogenic agents in BCs.

Suzuki K, Morita T, Tokue A. Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder. Int J Urol. 2005. https://doi.org/10.1111/j.1442-2042.2005.01010.x.

Article  PubMed  Google Scholar 

Nadaoka J, Horikawa Y, Saito M, Kumazawa T, Inoue T, Narita S, et al. Prognostic significance of HIF-1α polymorphisms in transitional cell carcinoma of the bladder. Int J Cancer. 2008. https://doi.org/10.1002/ijc.23256.

Article  PubMed  Google Scholar 

Szarvas T, Jäger T, Tötsch M, Vom Dorp F, Kempkensteffen C, Kovalszky I, et al. Angiogenic switch of Angiopietins-Tie2 System and its prognostic value in bladder cancer. Clin Cancer Res. 2008. https://doi.org/10.1158/1078-0432.CCR-08-0677.

Article  PubMed  Google Scholar 

Zaravinos A, Volanis D, Lambrou GI, Delakas D, Spandidos DA. Role of the angiogenic components, VEGFA, FGF2, OPN and RHOC, in urothelial cell carcinoma of the urinary bladder. Oncol Rep. 2012. https://doi.org/10.3892/or.2012.1948.

Article  PubMed  PubMed Central  Google Scholar 

Huang Y, Qi W, He A, Sun Y, Shen Z, Yao Y. Prognostic value of tissue vascular endothelial growth factor expression in bladder cancer: a meta-analysis. Asian Pac J Cancer Prev. 2013. https://doi.org/10.7314/APJCP.2013.14.2.645.

Article  PubMed  Google Scholar 

Theodoropoulos VE, Lazaris AC, Sofras F, Gerzelis I, Tsoukala V, Ghikonti I, et al. Hypoxia-inducible factor 1α expression correlates with angiogenesis and unfavorable prognosis in bladder cancer. Eur Urol. 2004. https://doi.org/10.1016/j.eururo.2004.04.008.

Article  PubMed  Google Scholar 

Donmez G, Sullu Y, Baris S, Yildiz L, Aydin O, Karagoz F, et al. Vascular endothelial growth factor (VEGF), matrix metalloproteinase-9 (MMP-9), and thrombospondin-1 (TSP-1) expression in urothelial carcinomas. Pathol Res Pract. 2009. https://doi.org/10.1016/j.prp.2009.07.015.

Article  PubMed  Google Scholar 

Chen W, Hung W, Kang W, Huang Y, Su Y, Yang C, et al. Overexpression of cyclooxygenase-2 in urothelial carcinoma in conjunction with tumor-associated-macrophage infiltration, hypoxia-inducible factor-1α expression, and tumor angiogenesis. APMIS. 2009. https://doi.org/10.1111/j.1600-0463.2008.00004.x.

Article  PubMed  Google Scholar 

Miao C, Liang C, Zhu J, Xu A, Zhao K, Hua Y, et al. Prognostic role of matrix metalloproteinases in bladder carcinoma: a systematic review and meta-analysis. Oncotarget. 2017; https://doi.org/10.18632/oncotarget.15907.

Tuncbilek N, Kaplan M, Altaner S, Atakan IH, Sut N, Inci O, et al. Value of dynamic contrast-enhanced MRI and correlation with tumor angiogenesis in bladder cancer. AJR Am J Roentgenol. 2009. https://doi.org/10.2214/AJR.08.1332.

Article  PubMed  Google Scholar 

Hassanien OA, Abouelkheir RT, Abou El-Ghar MI, Badawy ME, El Gamal SA, El-Hamid MA. Dynamic contrast-enhanced magnetic resonance imaging as a diagnostic tool in the assessment of tumour angiogenesis in urinary bladder cancer. Can Assoc Radiol J. 2019. https://doi.org/10.1016/j.carj.2018.11.004.

Article  PubMed  Google Scholar 

Barentsz JO, Berger-Hartog O, Witjes JA, Hulsbergen-van der Kaa C, Oosterhof GO, VanderLaak JA, et al. Evaluation of chemotherapy in advanced urinary bladder cancer with fast dynamic contrast-enhanced MR imaging. Radiology. 1998. https://doi.org/10.1148/radiology.207.3.9609906.

Article